ArticleJournal of ophthalmology2021
Functional Outcomes and Reading Speeds following PRESBYOND LBV Using Nonlinear Aspheric Ablation Profiles Combined with Micro-Monovision.
Article in Journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- Long-Term Outcomes of PRESBYOND Laser Correction for Presbyopia: A Retrospective Clinical Analysis.Journal of clinical medicine · 2026Article
- Evaluating the Efficacy and Safety of the LASIK Nonlinear Aspheric Micro-Monovision Surgery (Laser Blended Vision Surgery) in Correcting Presbyopia Among the Saudi Population.Healthcare (Basel, Switzerland) · 2026Article
- One-Year Outcomes and Satisfaction Following Non-Linear Aspheric Micro-Monovision LASIK (PRESBYOND) for Myopic and Hyperopic Presbyopia.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Current Trends in Presbyopia Correction-A Comprehensive Review.Journal of clinical medicine · 2025Review
- Contrast Sensitivity and Stereopsis Outcomes Following LASIK Presbyopia Correction Based on the Corneal Aberration Modulation or Corneal Multifocality Induction Methods: A Systematic Review.Journal of clinical medicine · 2025Review
- Outcomes of Corneal Compound Myopic Astigmatism with Presbyopia by Zeiss PRESBYONDJournal of clinical medicine · 2024Article
- Exploring the Effect of Preoperative Stereopsis on Visual Outcomes in Hyperopic Presbyopes Treated with PresbyONDJournal of clinical medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report the functional outcomes and reading speeds following PRESBYOND laser blended vision (LBV) using nonlinear aspheric ablation profiles with micro-monovision with the Carl Zeiss Meditec MEL 90 platform.
methodsData have been collected retrospectively for all patients who underwent PRESBYOND LBV using the MEL 90 excimer laser. Postoperative binocular uncorrected distance and near visual acuity, stereo-acuity, contrast sensitivity, and reading performance were compared with pre-op values measured with patient's progressive glasses. Mean follow-up was 6 ± 1.2 months.
resultsSixty eyes of 30 patients (mean age 50.47 ± 6.43 years) were included. Of these, 18 patients were hyperopic and 12 patients were myopic with mean SE of 1.28 ± 1.38 D and -2.84 ± 1.86 D, respectively. At 6 months, the mean binocular UDVA was ≥-0.03 ± 0.06 log MAR and the mean binocular UNVA was ≥0.22 ± 0.04 log MAR. The uncorrected reading speeds (words per minute) at the preferred reading distance of 46.17 cm, 60 cm, and 80 cm were significantly better (
conclusionPRESBYOND LBV resulted in significantly better reading speeds and satisfactory functional visual outcomes, without a permanent change in stereo-acuity and contrast sensitivity 6 months postoperatively.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.